{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T20:53:20Z","timestamp":1790456000187,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T00:00:00Z","timestamp":1754438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T00:00:00Z","timestamp":1754438400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Epidermolysis Bullosa Medical Research Foundation and Epidermolysis Bullosa Research Partnership"},{"DOI":"10.13039\/100000005","name":"The Department of Defense","doi-asserted-by":"crossref","award":["W81XWH-22-1-0272"],"award-info":[{"award-number":["W81XWH-22-1-0272"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-14413-1","type":"journal-article","created":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T12:13:38Z","timestamp":1754482418000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Natural history study of recessive dystrophic epidermolysis bullosa wounds and patient reported outcomes using mobile application home photography"],"prefix":"10.1038","volume":"15","author":[{"given":"Shivali","family":"Fulchand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaron","family":"Nazaroff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicki","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jodi Y.","family":"So","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Villanueva Gaona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estephannie","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shufeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Eid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Y.","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,6]]},"reference":[{"key":"14413_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41572-020-0210-0","volume":"6","author":"A Bardhan","year":"2020","unstructured":"Bardhan, A. et al. Epidermolysis Bullosa. Nat. Rev. Dis. Primers. 6, 1\u201327 (2020).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"14413_CR2","volume-title":"Fitzpatrick\u2019s Dermatology","author":"M Peter Marinkovich","year":"2019","unstructured":"Peter Marinkovich, M. Inherited epidermolyis Bullosa. In Fitzpatrick\u2019s Dermatology (McGraw-Hill Education, 2019)."},{"key":"14413_CR3","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s13023-021-01811-7","volume":"16","author":"JY Tang","year":"2021","unstructured":"Tang, J. Y. et al. A systematic literature review of the disease burden in patients with recessive dystrophic epidermolysis Bullosa. Orphanet J. Rare Dis. 16, 175 (2021).","journal-title":"Orphanet J. Rare Dis."},{"key":"14413_CR4","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1111\/bjd.18921","volume":"183","author":"C Has","year":"2020","unstructured":"Has, C. et al. Consensus reclassification of inherited epidermolysis Bullosa and other disorders with skin fragility. Br. J. Dermatol. 183, 614\u2013627 (2020).","journal-title":"Br. J. Dermatol."},{"key":"14413_CR5","doi-asserted-by":"crossref","unstructured":"Eichstadt, S. et al. Phase 1\/2a clinical trial of gene-corrected autologous cell therapy for recessive dystrophic epidermolysis Bullosa. JCI Insight 4, 1\u201311 (2019).","DOI":"10.1172\/jci.insight.130554"},{"key":"14413_CR6","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1001\/jama.2016.15588","volume":"316","author":"Z Siprashvili","year":"2016","unstructured":"Siprashvili, Z. et al. Safety andwound outcomes following genetically corrected autologous epidermal grafts in patients with recessive dystrophic epidermolysis Bullosa. JAMA - J. Am. Med. Association. 316, 1808\u20131817 (2016).","journal-title":"JAMA - J. Am. Med. Association"},{"key":"14413_CR7","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1016\/j.jid.2018.11.036","volume":"139","author":"MP Marinkovich","year":"2019","unstructured":"Marinkovich, M. P. & Tang, J. Y. Gene therapy for epidermolysis Bullosa. J. Invest. Dermatol. 139, 1221\u20131226 (2019).","journal-title":"J. Invest. Dermatol."},{"key":"14413_CR8","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1056\/NEJMoa2206663","volume":"387","author":"SV Guide","year":"2022","unstructured":"Guide, S. V. et al. Trial of beremagene geperpavec (B-VEC) for dystrophic epidermolysis Bullosa. N Engl. J. Med. 387, 2211\u20132219 (2022).","journal-title":"N Engl. J. Med."},{"key":"14413_CR9","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1093\/bjd\/ljac001","volume":"188","author":"JS Kern","year":"2023","unstructured":"Kern, J. S. et al. Efficacy and safety of Oleogel-S10 (birch triterpenes) for epidermolysis bullosa: results from the phase III randomized double-blind phase of the EASE study. Br. J. Dermatol. 188, 12\u201321 (2023).","journal-title":"Br. J. Dermatol."},{"key":"14413_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/d41573-025-00082-2","author":"A Mullard","year":"2025","unstructured":"Mullard, A. FDA approves cell-sheet-based gene therapy for severe skin disease. Nat. Rev. Drug Discov. https:\/\/doi.org\/10.1038\/d41573-025-00082-2 (2025).","journal-title":"Nat. Rev. Drug Discov"},{"key":"14413_CR11","doi-asserted-by":"crossref","unstructured":"Paller, A. et al. Efficacy and tolerability of the investigational topical cream SD-101 (6% allantoin) in patients with epidermolysis bullosa: a phase 3, randomized, double-blind, vehicle-controlled trial (ESSENCE study). Orphanet J. Rare Diseases 15, 1\u201311 (2020).","DOI":"10.1186\/s13023-020-01419-3"},{"key":"14413_CR12","unstructured":"Writer, G. S. Amicus Halts Development of SD-101 after Phase III Failure. GEN - Genetic Engineering and Biotechnology News. https:\/\/www.genengnews.com\/news\/amicus-halts-development-of-sd-101-after-phase-iii-failure\/ (2017)."},{"key":"14413_CR13","doi-asserted-by":"publisher","first-page":"157","DOI":"10.2340\/00015555-2786","volume":"98","author":"BM Kyaw","year":"2018","unstructured":"Kyaw, B. M. et al. Need for improved definition of \u2018chronic wounds\u2019 in clinical studies. Acta Derm Venereol. 98, 157\u2013158 (2018).","journal-title":"Acta Derm Venereol."},{"key":"14413_CR14","doi-asserted-by":"crossref","unstructured":"Zhao, R., Liang, H., Clarke, E., Jackson, C. & Xue, M. Inflammation in chronic wounds. Int. J. Mol. Sci. 17, 1\u201314 (2016).","DOI":"10.3390\/ijms17122085"},{"key":"14413_CR15","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1016\/j.ajpath.2017.03.003","volume":"187","author":"F Cianfarani","year":"2017","unstructured":"Cianfarani, F., Zambruno, G., Castiglia, D. & Odorisio, T. Pathomechanisms of altered wound healing in recessive dystrophic epidermolysis Bullosa. Am. J. Pathol. 187, 1445\u20131453 (2017).","journal-title":"Am. J. Pathol."},{"key":"14413_CR16","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.1016\/j.jid.2017.02.234","volume":"137","author":"D Solis","year":"2017","unstructured":"Solis, D. et al. Natural history of chronic wounds in patients with recessive dystrophic epidermolysis Bullosa. J. Invest. Dermatol. 137, S37 (2017).","journal-title":"J. Invest. Dermatol."},{"key":"14413_CR17","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/j.jaad.2020.03.028","volume":"85","author":"VA Eng","year":"2021","unstructured":"Eng, V. A. et al. Patient-reported outcomes and quality of life in recessive dystrophic epidermolysis bullosa: A global cross-sectional survey. J. Am. Acad. Dermatol. 85, 1161\u20131167 (2021).","journal-title":"J. Am. Acad. Dermatol."},{"key":"14413_CR18","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1111\/pde.14802","volume":"38","author":"S Fulchand","year":"2021","unstructured":"Fulchand, S. et al. Patient-reported outcomes and quality of life in dominant dystrophic epidermolysis bullosa: A global cross-sectional survey. Pediatr. Dermatol. 38, 1198\u20131201 (2021).","journal-title":"Pediatr. Dermatol."},{"key":"14413_CR19","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1016\/j.jaad.2020.08.118","volume":"85","author":"DC Solis","year":"2021","unstructured":"Solis, D. C. et al. Classification of 2 distinct wound types in recessive dystrophic epidermolysis bullosa: A retrospective and cohort natural history study. J. Am. Acad. Dermatol. 85, 1296\u20131298 (2021).","journal-title":"J. Am. Acad. Dermatol."},{"key":"14413_CR20","volume-title":"Epidermolysis Bullosa: Developing Drugs for Treatment of Cutaneous Manifestations","author":"Department of Health and Human Services (U.S.)","year":"2019","unstructured":"Department of Health and Human Services (U.S.). Food and drug administration (U.S.), center for biologics evaluation and research (U.S.) & center for drug evaluation and research. In Epidermolysis Bullosa: Developing Drugs for Treatment of Cutaneous Manifestations (Center for Drug Evaluation and Research, 2019)."},{"key":"14413_CR21","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1111\/pde.14576","volume":"38","author":"DC Solis","year":"2021","unstructured":"Solis, D. C. et al. Clinical characteristics associated with increased wound size in patients with recessive dystrophic epidermolysis Bullosa. Pediatr. Dermatol. 38, 704\u2013706 (2021).","journal-title":"Pediatr. Dermatol."},{"key":"14413_CR22","doi-asserted-by":"crossref","unstructured":"Bruckner-Tuderman, L. & Mellerio, J. e. Wound healing in epidermolysis bullosa. British Journal of Dermatology 177, e193\u2013e195 (2017).","DOI":"10.1111\/bjd.15572"},{"key":"14413_CR23","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.2089","volume":"9","author":"CA Schneider","year":"2012","unstructured":"Schneider, C. A., Rasband, W. S. & Eliceiri, K. W. NIH image to imageJ: 25 years of image analysis. Nat. Methods. 9, 671\u2013675 (2012).","journal-title":"Nat. Methods"},{"key":"14413_CR24","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/S0304-3959(00)00375-4","volume":"89","author":"DL Wong","year":"2001","unstructured":"Wong, D. L. & Baker, C. M. Smiling faces as anchor for pain intensity scales. Pain 89, 295\u2013300 (2001).","journal-title":"Pain"},{"key":"14413_CR25","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1097\/BCR.0b013e3182372bfa","volume":"33","author":"V Morris","year":"2012","unstructured":"Morris, V. et al. Itch assessment scale for the pediatric burn survivor. J. Burn Care Res. 33, 419\u2013424 (2012).","journal-title":"J. Burn Care Res."},{"key":"14413_CR26","unstructured":"NCT02384460 & Phase, A. 3, Multi-center, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of SD-101 Cream in Patients With Epidermolysis Bullosa. (2020)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-14413-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-14413-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-14413-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T21:47:54Z","timestamp":1757368074000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-14413-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,6]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["14413"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-14413-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,6]]},"assertion":[{"value":"18 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"J.Y.T. an investigator for clinical trials sponsored by Abeona Therapeutics, Inc., and Phoenix Tissue Repair. All the remaining authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Stanford University Institutional Review Board and informed consent for participation was obtained from all the study participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval\u00a0<!--Emphasis Type='Bold' removed-->and informed consent to participate"}},{"value":"All participants provided informed consent for their data to be included in this publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent\u00a0<!--Emphasis Type='Bold' removed-->for publication"}}],"article-number":"28767"}}